4.6 Article

Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Substrate reduction therapy using Genz-667161 reduces levels of pathogenic components in a mouse model of neuronopathic forms of Gaucher disease

Shani Blumenreich et al.

Summary: The study showed that SRT is effective in reversing the pathological components and pathways of substrate accumulation in nGD brain by inhibiting the synthesis of glycosphingolipids to reduce their accumulation. This approach can reverse the changes in GSL metabolism, lipoproteins, and other lipid metabolic pathways associated with CBE injection, demonstrating the potential of SRT in treating nGD with a neurological component.

JOURNAL OF NEUROCHEMISTRY (2021)

Review Endocrinology & Metabolism

Gaucher disease: Basic and translational science needs for more complete therapy and management

Gregory A. Grabowski et al.

MOLECULAR GENETICS AND METABOLISM (2021)

Review Medicine, General & Internal

Impaired autophagy: The collateral damage of lysosomal storage disorders

Rachel Myerowitz et al.

Summary: Lysosomal storage disorders are caused by mutations in genes encoding proteins involved in lysosomal function, leading to abnormal storage and autophagic dysfunction. Although different LSDs affect diverse lysosomal functions, they all uniquely impair the autophagic process when mutant.

EBIOMEDICINE (2021)

Review Pharmacology & Pharmacy

Current and emerging pharmacotherapy for Gaucher disease in pediatric populations

Richard Sam et al.

Summary: In recent decades, significant progress has been made in the treatment of Gaucher disease, especially for pediatric patients. New pharmacotherapies are under development, with potential options such as gene therapy or small molecule glucocerebrosidase chaperones. The focus is on achieving a cure for systemic disease manifestations and improving treatment cost and convenience, particularly for pediatric patients.

EXPERT OPINION ON PHARMACOTHERAPY (2021)

Article Cell & Tissue Engineering

Elevated glucosylsphingosine in Gaucher disease induced pluripotent stem cell neurons deregulates lysosomal compartment through mammalian target of rapamycin complex 1

Manasa P. Srikanth et al.

Summary: Gaucher disease is caused by mutations in the GBA1 gene, leading to the accumulation of GlcSph which activates an mTORC1-dependent pathogenic mechanism in neurons. Inhibition of acid ceramidase can prevent mTOR hyperactivity and lysosomal dysfunction, suggesting a potential therapeutic target for GBA1-associated neurodegeneration. Incubation with exogenous GlcSph in wild-type neurons can recapitulate the abnormalities observed in mutant neurons, highlighting the role of GlcSph in the pathogenesis of Gaucher disease.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

Review Biochemistry & Molecular Biology

Lysosome biogenesis in health and disease

Lakshya Bajaj et al.

JOURNAL OF NEUROCHEMISTRY (2019)

Article Cell Biology

mTOR hyperactivity mediates lysosomal dysfunction in Gaucher's disease iPSC-neuronal cells

Robert A. Brown et al.

DISEASE MODELS & MECHANISMS (2019)

Article Biochemical Research Methods

Mitochondrial membrane potential

Ljubava D. Zorova et al.

ANALYTICAL BIOCHEMISTRY (2018)

Article Cell Biology

Multistep regulation of TFEB by MTORC1

Silvia Vega-Rubin-de-Celis et al.

AUTOPHAGY (2017)

Article Biochemistry & Molecular Biology

Modulating ryanodine receptors with dantrolene attenuates neuronopathic phenotype in Gaucher disease mice

Benjamin Liou et al.

HUMAN MOLECULAR GENETICS (2016)

Review Biochemistry & Molecular Biology

Mitochondrial dysfunction in Parkinson's disease

Anindita Bose et al.

JOURNAL OF NEUROCHEMISTRY (2016)

Article Biotechnology & Applied Microbiology

CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher Disease

John Marshall et al.

MOLECULAR THERAPY (2016)

Article Biochemistry & Molecular Biology

Altered TFEB-mediated lysosomal biogenesis in Gaucher disease iPSC-derived neuronal cells

Ola Awad et al.

HUMAN MOLECULAR GENETICS (2015)

Correction Genetics & Heredity

Novel mutations in the glucocerebrosidase gene of Indian patients with Gaucher disease (vol 59, pg 223, 2014)

Chitra Ankleshwaria et al.

JOURNAL OF HUMAN GENETICS (2015)

Article Biochemistry & Molecular Biology

Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice

You-hai Xu et al.

HUMAN MOLECULAR GENETICS (2014)

Article Biochemistry & Molecular Biology

Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage

Michael W. J. Cleeter et al.

NEUROCHEMISTRY INTERNATIONAL (2013)

Article Pharmacology & Pharmacy

Mitochondrial Dysfunction in Neurodegenerative Diseases

Ashu Johri et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)

Review Biochemical Research Methods

Cytometric Assessment of Mitochondria Using Fluorescent Probes

Cecile Cottet-Rousselle et al.

CYTOMETRY PART A (2011)

Editorial Material Cell Biology

Impaired autophagosomes and lysosomes in neuronopathic Gaucher disease

Ying Sun et al.

AUTOPHAGY (2010)

Review Biochemistry & Molecular Biology

Multi-system disorders of glycosphingolipid and ganglioside metabolism

You-Hai Xu et al.

JOURNAL OF LIPID RESEARCH (2010)

Article Medicine, General & Internal

Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease

E. Sidransky et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Biochemistry & Molecular Biology

A block of autophagy in lysosomal storage disorders

Carmine Settembre et al.

HUMAN MOLECULAR GENETICS (2008)

Article Clinical Neurology

Mitochondrial alterations in dorsal root ganglion cells in sporadic amyotrophic lateral sclerosis

Shoichi Sasaki et al.

ACTA NEUROPATHOLOGICA (2007)

Article Multidisciplinary Sciences

Murine models of acute neuronopathic Gaucher disease

Ida Berglin Enquist et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Genetics & Heredity

Perinatal-lethal Gaucher disease

C Mignot et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2003)

Article Genetics & Heredity

Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease

V Koprivica et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2000)